|
|
Gene Symbol |
ADRB3 |
|
Aliases |
BETA3AR |
|
Entrez Gene ID |
|
|
Gene Name |
Adrenoceptor beta 3 |
|
Chromosomal Location |
8p11.23 |
|
HGNC ID |
|
|
Summary |
The protein encoded by this gene belongs to the family of beta adrenergic receptors, which mediate catecholamine-induced activation of adenylate cyclase through the action of G proteins. This receptor is located mainly in the adipose tissue and is involved in the regulation of lipolysis and thermogenesis. Obesity and bodyweight-related disorders are correlated with certain polymorphisms in three subtypes of beta-adrenoceptor, among them, the ADRB3 gene.[provided by RefSeq, Oct 2019]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Beta-3 adrenergic receptor, adrenergic, beta-3-, receptor, beta-3 adrenoceptor, beta-3 adrenoreceptor |
|
Function |
Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. Beta-3 is involved in the regulation of lipolysis and thermogenesis |
|
|
|
|
|
UniProt |
|
|
PDB |
|
|
Pfam |
Pfam Accession |
Pfam ID |
PF00001 |
7tm_1 |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000269856 |
|
Q9BSK4 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Heart Failure |
|
Myocardial Failure |
|
Left Ventricular Hypertrophy |
|
Endocrine System Diseases |
PCOS |
|
Nutritional and Metabolic Diseases |
Obesity |
8954053, 9814483, 9892244, 8903328, 9100608, 10323390, 7609750, 9449691, 7609752, 9054940, 10999801, 10323402, 9112025, 11095426, 15472194, 9709965 |
Hyperlipidemia |
|
Psychiatric/Brain disorders |
Mental Depression |
|
Schizophrenia |
|
Obstructive Sleep Apnea |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
CYP21 mutations,HSD3B2 variants,IRS-1, GRL |
Hyperandrogenism |
ADRB3 variants |
|
Related
|
|
Our findings suggest that the development of PP and HA can be associated with the occurrence of multiple sequence variants at five susceptibility loci, especially steroidogenic enzyme genes. |
|
|
|
|